Patent · US Active

Sultiame for the treatment of sleep apnea

US10617694B2 · kind B2 · utility

3Cited by
3References
11Claims
0Family size

Inventors

Key dates

Filing dateMay 9, 2017
Grant dateApr 14, 2020
Priority date—
Expiry dateMay 9, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided for novel therapy of sleep apnea that involves administering the drug sultiame to the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.